SNPHY(SNPHY)
SNPHY
$11.95—Stale · unknown old
OTC • Last print unknown ago
$11.95—Stale · unknown old
No analyst ratings available
No analyst price targets available for SNPHY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $309.37B | $328.40B |
| Low | $301.44B | $319.99B |
| High | $316.60B | $336.08B |
| EBITDA Avg | $68.88B | $80.15B |
| Low | $67.32B | $78.21B |
| High | $70.31B | $81.92B |
| EBIT Avg | $49.55B | $60.70B |
| Low | $47.98B | $58.76B |
| High | $50.98B | $62.46B |
| Net Income Avg | $39.59B | $48.97B |
| Low | $38.28B | $47.34B |
| High | $40.80B | $50.46B |
| EPS Avg | $120.57 | $149.13 |
| Low | $116.56 | $144.17 |
| High | $124.24 | $153.66 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $71.19B | $77.63B |
| Low | $69.44B | $75.27B |
| High | $72.23B | $79.13B |
| EBITDA Avg | $20.50B | — |
| Low | $20.01B | — |
| High | $20.79B | — |
| EBIT Avg | $15.74B | — |
| Low | $15.26B | — |
| High | $16.03B | — |
| Net Income Avg | $12.80B | — |
| Low | $12.39B | — |
| High | $13.04B | — |
| EPS Avg | $39.66 | — |
| Low | $38.40 | — |
| High | $40.41 | — |
| Analysts (Rev / EPS) | 2 / 1 | 3 / — |